Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
61.25 INR
31.73 B INR
287.25 B INR
274.12 M
About AUROBINDO PHARMA LTD
Sector
CEO
Kambam Nithyananda Reddy
Headquarters
Hyderabad
Website
Founded
1986
ISIN
INE406A01037
FIGI
BBG000BMFT44
Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. It operates under the following geographical segments: India, USA, Europe, and Rest of the World. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.
Aurobindo Pharma Cmp 1263 Reversed from SupportAurobindo Pharma Cmp 1263 dated 29-11-2024
1. Reversed from Support
2. Cup Pattern In RSI
Buy @ Cmp or safe traders buy above 1275 SL 1210
target 1280-1300-1315-1330-1340-1360
It is just a view, please trade at your own risk
Auro Pharma - Low Risk High Reward CallStock at strong support & flip zone area
1380-1395 strong area
If stock sustains this area then may flip and go higher again
View negates below 1370
Upside 1515 -1520 possible
AUROPHARMA - About to complete the 5thAUROPHARMA: CMP 1466
Price likely to go one more high towards 1620-1650 and profit booking could be seen from that level.. Chart is attached for reference
auropharma huge PE opportunity1400 ce at 7.50 now.
below 1457 it has massive weakness. As suggested by Fib as well.
targets on downside are 1380 // 1355 // 1325.
other factors are that
1.the monthly candle that broke rsi80 has been broken down.
2.daily candle that broke rsi40 is still intact, price hasnt broken and closed a
A 5* GFS TRADE ON AUROPHARMAGFS Trade active on AUROPHARMA , can enter above high of green candle(1509) and keeping SL (1470)as red candle low.Can be traded for 1:2 to 1:3 RR, swing trade
Auropharma - Flag Pole breakoutAuropharma :
Flag Pole breakout in progress
Looks good only above 1600 with support of 1560
Auropharma Buy above 1518 and Target 1632Auropharma strong support in 1518 its sustain above will reach 1632
Super strong trendAuropharma CMP 1538
9 years of consolidation. Now that it has been broken it has a long way to go. Next resistance at 1820.
Buy Aurobindo Pharma Short Term Trading Advice by Goodluck Capital
Buy Aurobindo Pharma
Buy Range- 1240 - 1260
Target- 1330 - 1350
StopLoss- below 1175
Potential Return- 6-8%
Approx trade duration 9 - 10 days
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AUROPHARMA is 1,207.95 INR — it has decreased by −0.59% in the past 24 hours. Watch AUROBINDO PHARMA LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange AUROBINDO PHARMA LTD. stocks are traded under the ticker AUROPHARMA.
AUROPHARMA stock has fallen by −3.71% compared to the previous week, the month change is a −4.96% fall, over the last year AUROBINDO PHARMA LTD. has showed a 16.23% increase.
We've gathered analysts' opinions on AUROBINDO PHARMA LTD. future price: according to them, AUROPHARMA price has a max estimate of 1,930.00 INR and a min estimate of 1,225.00 INR. Watch AUROPHARMA chart and read a more detailed AUROBINDO PHARMA LTD. stock forecast: see what analysts think of AUROBINDO PHARMA LTD. and suggest that you do with its stocks.
AUROPHARMA reached its all-time high on Sep 13, 2024 with the price of 1,592.55 INR, and its all-time low was 10.15 INR and was reached on Nov 6, 2008. View more price dynamics on AUROPHARMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AUROPHARMA stock is 3.68% volatile and has beta coefficient of 0.85. Track AUROBINDO PHARMA LTD. stock price on the chart and check out the list of the most volatile stocks — is AUROBINDO PHARMA LTD. there?
Today AUROBINDO PHARMA LTD. has the market capitalization of 701.58 B, it has decreased by −2.12% over the last week.
Yes, you can track AUROBINDO PHARMA LTD. financials in yearly and quarterly reports right on TradingView.
AUROBINDO PHARMA LTD. is going to release the next earnings report on Feb 14, 2025. Keep track of upcoming events with our Earnings Calendar.
AUROPHARMA earnings for the last quarter are 14.00 INR per share, whereas the estimation was 16.05 INR resulting in a −12.75% surprise. The estimated earnings for the next quarter are 15.42 INR per share. See more details about AUROBINDO PHARMA LTD. earnings.
AUROBINDO PHARMA LTD. revenue for the last quarter amounts to 77.96 B INR, despite the estimated figure of 77.88 B INR. In the next quarter, revenue is expected to reach 76.70 B INR.
AUROPHARMA net income for the last quarter is 8.17 B INR, while the quarter before that showed 9.19 B INR of net income which accounts for −11.08% change. Track more AUROBINDO PHARMA LTD. financial stats to get the full picture.
As of Dec 15, 2024, the company has 37.60 K employees. See our rating of the largest employees — is AUROBINDO PHARMA LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AUROBINDO PHARMA LTD. EBITDA is 64.74 B INR, and current EBITDA margin is 19.89%. See more stats in AUROBINDO PHARMA LTD. financial statements.
Like other stocks, AUROPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AUROBINDO PHARMA LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AUROBINDO PHARMA LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AUROBINDO PHARMA LTD. stock shows the buy signal. See more of AUROBINDO PHARMA LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.